Advertisement
Home Tags Blood Disorders

Tag: Blood Disorders

Terlipressin therapy can induce hyponatremia

Terlipressin Therapy Can Induce Hyponatremia

0
Case report describes 41-year-old man with variceal rebleeding treated with terlipressin
For patients with ovarian cancer

Pre-Op Blood Tests May Predict Post-Op Morbidity in Ovarian CA

0
Pre-op thrombocytosis, leukocytosis tied to post-op morbidity; increased mortality for patients with both
Cardiac surgery patients given blood stored for more than six weeks face no greater harm than those who get blood donated within two weeks

Older Blood Appears Safe for Cardiac Surgery Patients

0
Storage duration doesn't affect complications, mortality rate
Coagadex (coagulation Factor X) has been approved by the U.S. Food and Drug Administration as the first coagulation factor replacement therapy for people with a rare blood disorder known as hereditary Factor X deficiency.

FDA Approves Coagadex for Rare Clotting Disorder

0
First coagulation therapy sanctioned for Factor X deficiency
Magnetic resonance imaging is an accurate and safe tool for the detection of low levels of iron overload in patients with hereditary hemochromatosis

MRI Effectively Measures Hemochromatosis Iron Burden

0
MRI tested in detection of iron stores in heart, liver and spleen, and pancreas
For patients undergoing total hip arthroplasty or total knee arthroplasty

Increased BMI Protective Against Blood Transfusions

0
Findings among patients undergoing total hip, knee arthroplasty
For patients in intensive care units who need a catheter

Subclavian Vein Catheterization Beats Jugular, Femoral Placement

0
Reduces risk of blood infection, deep-vein thrombosis among critically ill
Imetelstat

Imetelstat Deemed Active in Myelofibrosis, Thrombocythemia

0
Responses for patients with myelofibrosis, essential thrombocythemia
An experimental blood test may one day detect the return of early-stage breast cancer months before it is revealed by computed tomography or magnetic resonance imaging

Blood Test Predicts Relapse in Early-Stage Breast Cancer

0
Circulating tumor DNA analysis spots stray cells months before scans detect recurrence
Daratumumab monotherapy has a favorable safety profile and encouraging efficacy in patients with heavily pretreated and refractory myeloma in a phase 1-2 trial. The results of the study were published online Aug. 26 in the New England Journal of Medicine.

Daratumumab Monotherapy Promising for Multiple Myeloma

0
Findings in a phase 1-2 study of patients with relapsed myeloma or relapsed/refractory myeloma